Herpes Treatments Blog

Welcome to Best-Herpes-Treatments.com herpes blog. This blog is designed to show you what is happening at Best Herpes Treatments .com and also to share herpes treatment news that are not displayed elsewhere on this website.

[AD]

Cure Herpes Symptoms Naturally in 48h

If you want information and guidelines on natural herpes remedies that can help you stop genital herpes symptoms in 3 days without reaching blister stage, I recommend you read Herpes Wise. The information in this book has helped me remain herpes symptoms free for more than 3 years now. Visit Herpes Wise now



Feb 8, 2010, A New Kind of STD Prevention: Mechanical Orgasm

According to H+magazine’s Hank Hyena (not a pseudonym, of course!), scientists predict fully-functioning sex robots by the end of next year (2011). They will be programmed from the finest sex manuals to provide the best sex imaginable without the need for courtship or romance.

Hyena writes: “Remember the most compulsive, brain-ripping climax you ever had? Sexbots (sic) will electrocute our flesh with climaxes twice as gigantic because they’ll be more desirable, patient, eager and altruistic…”

Leaving aside for a moment just how a piece of machinery can be desirable or eager, one of the immediate and obvious benefits of mechanically-induced orgasm is that a robot can neither contract nor transmit sexually transmitted disease. Another advantage, according to the author is that orgasms: “ reduce stress, insomnia, heart attacks, migraines, depression, addictions, aches, pains, menstrual cramps…..

Actually I think that such an invention is extremely dangerous and could cut the growing number of cyber or virtual sex addicts even further from reality creating new phantasms that no human being could match.

Permalink -- click for full blog post "A New Kind of STD Prevention: Mechanical Orgasm"


Feb 6, 2010, New Herpes Prevention Vaccine?

Professor William Halford, associate professor of medical microbiology, immunology and cell biology at Southern Illinois University School of Medicine claims controversial research has provided him with “the future genital herpes vaccine”.

His technique has been criticized as unsafe, as it uses the entire, live herpes virus, rather than a piece of protein taken from it. This flies in the face of most research since the 1970s, but Halford argues that if it worked in older childhood vaccines against measles, mumps and rubella, there is no scientific reason to argue it won’t work against herpes.

With the help of a $400k grant from the National Institute of Health, Halford claims to have successfully changed the herpes simplex virus 2 by altering a gene known as ICPO, so that the virus no longer produces herpes symptoms.

So far, successful experiments have been carried out only on laboratory mice and, due to the nature of the research, it could be several years before a vaccine becomes available for human trials.

Nonetheless, said SIU medical schools associate dean, Linda Toth: “ A lot of people could potentially benefit in terms of preventing the contraction of what’s essentially a lifelong disease….He’s certainly got a novel approach.”

Permalink -- click for full blog post "New Herpes Prevention Vaccine?"


Feb 6, 2010, Genital Herpes Spreads on Several Locations at the Same Time

Because recurring symptoms of genital herpes tend to erupt in the same part of the body, treatment and prevention of the disease have been based around this phenomenon.

But new research from the University of Washington and Fred Hutchinson Cancer Research Center in Seattle now appears to show that the herpes virus frequently reactivates throughout the genital tract. In the study, lead scientist Christine Johnston MD MPH and her colleagues collected samples from four HSV2 infected women, taken from seven separate genital sites over a 30 day period. On 56 percent of days when viral shedding was detected, HSV2 was found on more than one anatomical site, and on genital surfaces on both sides of the body.

Allowing for the small size of their sample group, the report’s authors nonetheless wrote that the study’s findings illustrate an important new concept in HSV-2 pathogenesis which may be helpful in developing treatments for the suppression and limitation of HSV-2 infection.

Edward W. Hook III, of the University of Alabama, said the study was “Of great potential importance”, challenging widely held beliefs about the virus and its management.

Available online, the study appears in full in the Journal of Infectious Diseases (Feb 15)

Permalink -- click for full blog post "Genital Herpes Spreads on Several Locations at the Same Time"


Jan 18, 2010, Herpes and Pregancy: when should you get a C-section

I have found this nice summary of what mothers should expect during pregnancy. This article was written by French medical doctors. American doctors tend to use C-sections more systematically.
-----------------------------------
Neonatal herpes is revealing maternal herpes in 2/3 of cases. In case of primary infection just before delivery, caesarian section is recommanded, as is the treatment with aciclovir of the neonate. In case of recurrence just before delivery caesarean section is also recommended. In case of history of herpes lesions, normal delivery is possible, after local disinfection with betadine. A positive local sample, at this time, should initiate a treatment with acyclovir for the neonate. Serological assays are, by now, of no use in this situation.Link to the article

Permalink -- click for full blog post "Herpes and Pregancy: when should you get a C-section"


Dec 7, 2009, Shingles and Chickenpox vaccine

Recent research in California published in The Pediatric Infectious Disease Journal indicates that the incidence of shingles (herpes zoster) may be reduced in children who have been vaccinated against chickenpox (varicella)

Children under ten who had been vaccinated were found to have significantly fewer shingles infections than those who had not. Shingles infection in infants is far less common than in the adult population. It is hoped that this apparent protection against shingles may last into adulthood, but until follow-up research can be conducted, scientists will not know.

Permalink -- click for full blog post "Shingles and Chickenpox vaccine"


Dec 7, 2009, Herpes Infection Non-Disclosure and Your Money

A lawsuit taken by a Tampa Bay (FL) woman could have negative effects in the fight against transmission of Herpes and other STDs. Kathy Croman (57) filed against former boyfriend Richard Tinker, claiming Tinker infected her with herpes without telling her he was a carrier until well into their sexual relationship. Failure to disclose herpes is a misdemeanour in Florida and certain other states. Could it be coincidence that Tinker is a millionaire?

Herpes is a serious business, not to be used as a cash cow in the law courts by people old enough to know better.

Permalink -- click for full blog post "Herpes Infection Non-Disclosure and Your Money"


Dec 7, 2009, STDs and Teenage Girls

Recent research published by Pediatrics shows nearly 25 percent of sexually active teenage girls in the US to be infected with at least one sexually transmitted infection (SDI). The sample of 838 teenage girls (aged 14 to 19) was tested for gonorrhoea, chlamydia, trichomoniasis, herpes simplex virus type 2 and human papillomavirus (HPV)

Researchers say their main concern is how soon after teenage girls began engaging in sexual activity these diseases presented. The study, which included interviews and medical examinations, found that within just one year of first sexual activity, 19.2% of girls had contracted a sexually transmitted infection (STI).

“The prevalence of STIs among female adolescents is substantial,” said Sara E Forhan MD on behalf of the research team, adding: “STIs begin to be acquired soon after sexual initiation and with few sex partners.”

The presence of a sexually transmitted infection does not automatically mean the subject will develop disease symptoms, but some infections can lead to long-term complications including cervical cancer, infertility and even an increased risk of becoming infected with HIV.

The most common SDI found in the sample was HPV (18.3% of sample infected) followed by Chlamydia (3.9%)

The research team concluded: “These findings highlight the importance of both primary and secondary STI prevention, including early, skill-based sex education; HPV vaccination of pre-adolescent girls and Chlamydia screening of all sexually active female adolescents.”

The study found significant differences in infection rates according to ethnicity. Nearly 50% of African American girls were infected, compared with approximately 20% of caucasian girls. http://www.gwumc.edu/sphhs/about/rapidresponse/download/Rapid_TeenSTD_Final.pdf

The study was conducted by the George Washington University Medical Center.

Permalink -- click for full blog post "STDs and Teenage Girls"


Oct 27, 2009, Who Gave You Herpes?

Would you like to know who gave you herpes and when? There is only one way to find out. Watch this video now.

If you want to gain access to more videos about herpes answering your most burning herpes questions, visit http://herpes-antidote.com

Permalink -- click for full blog post "Who Gave You Herpes?"


Sep 17, 2009, What? Almond Skin Could Stop Herpes Type 2, HSV-2 Replication

NEW YORK (Reuters Health) - Lab experiments indicate that almonds have the potential to boost immune health and reduce inflammation, according to research reported Tuesday at the annual meeting of the American Society for Microbiology in Philadelphia.Almonds, study presenter Dr. Giuseppina Mandalari told Reuters Health, may have a "helpful impact on the treatment of infective and chronic diseases." She said almond skins can modulate an immunological response "and positively act as novel antiviral agents."

Mandalari, from the Institute of Food Research, Norwich, UK, and colleagues evaluated the effects of natural and blanched almond skins on the release of immunological compounds in cells either infected or not infected with the genital herpes virus HSV-2.The addition of natural almond skins to the cells led to a "significant decrease in HSV-2 replication, whereas other extracts did not significantly influence the replication of the virus," according to the team's meeting materials.The study was funded by the Almond Board of California.

UK Research shows Almonds may help in herpes treatment.

Laboratory experiments conducted by the Institute of Food Research in Norwich (UK) have indicated that Almonds may play a part in the treatment of genital herpes with their potential to boost the immune system and reduce inflammation.According to Dr Giuseppina Mandalari, presenting the study results to the American Society for Microbiology in Philadelphia, almond skins can “positively act as novel antiviral agents.”

The Norwich study found that the addition of natural almond skins to HSV-2 cells led to “a significant decrease in HSV-2 replication, whereas other extracts did not significantly influence the replication of the virus.”

Permalink -- click for full blog post "What? Almond Skin Could Stop Herpes Type 2, HSV-2 Replication"


Sep 17, 2009, Encouraging Results from Cold Sore/Facial Herpes Drug Test

Preliminary test results from Paris-based BioAlliance Pharma group show their antiviral acyclovir Lauriad® reduced the healing time for patients with facial herpes lesions, as well as preventing the onset of lesions in some patients who presented prodromal symptoms (e.g. initial tingling).

The trial used a single-dose of the drug with a single-dose placebo as the control and included 722 patients with recurrent orofacial (cold sore type) herpes. The new drug uses the same tablet technology as Loramyc®, the group’s oral thrush (oropharyngeal candidiasis) treatment drug, which is already licensed in the United States and much of Europe.

Permalink -- click for full blog post "Encouraging Results from Cold Sore/Facial Herpes Drug Test"


Jul 27, 2009, You Have a 70% Chance of Getting Herpes even if you use a Condom

Up until recently, scientific research estimated the increase of transmission protection given by the use of condoms of 50%. A recent study conducted by researchers at the University of Washington, the federal Centers for Disease Control and Prevention and other centers reduced that number to 30% for HSV-2 genital herpes.

In other words, you only have 30% less chance of catching herpes from someone who has genital herpes type 2 if you use condoms each and every time.

This number seems quite small but when combined with other transmission risk management strategies it can increase to 80% to 90% limiting transmission risks to 10%.

For example, it seems that the longer a relationship, the less likely a person is to catch herpes from his/her partner so faithfulness and fidelity seems to pay off.

If you want to learn more about herpes transmission please visit http://www.herpes-antidote.com

Permalink -- click for full blog post "You Have a 70% Chance of Getting Herpes even if you use a Condom"


Jul 13, 2009, Herpes and Viral Detection Breakthrough in sight

In a medical breakthrough, a device first used to detect the herpes simplex virus is in prototype and could soon be used to detect the presence of any bacterium or virus in the human body.

If this device is as good as it promises to be, then the latest worrying and wondering over epidemics like swine fever will become a thing of the past.

The device works on the principle of light refraction. If any type of molecule gets in the way of a minute beam of light, the light will refract, or scatter. Just like fingerprints are unique to all people, so the pattern of light refraction or scattering is different for every molecule. So once you suspect that a viral or bacterial infection exists, you aim a beam of light at it and watch the refraction. Match the pattern with a database of viral patterns and you have an instant diagnosis.

It’s a long way from prototype to production line, but scientists are hopeful that before long it will be possible to analyse a sample of blood or saliva from a patient almost instantly in this way. Such a breakthrough in medical science could save millions of dollars in conventional testing methods.

Permalink -- click for full blog post "Herpes and Viral Detection Breakthrough in sight"


Jul 7, 2009, Vitamin E Helps Fight Cold Sores and Genital Herpes 1

Previous laboratory studies have shown that dietary vitamin E (alpha tocopherol) is important for regulating the immune response in the brain to HSV-1 infection.

A recent study involved rats that were given vitamin E-deficient diets for four weeks followed by intranasal infection with HSV-1. The researchers found out that adequate levels of vitamin E are important for transporting and directing antigen-specific T-cells to the brain. This enables T-cells to fight and destroy brain cells that have been infected with HSV-1.

T-cells belong to a group of white blood cells known as lymphocytes, and play a central role in the immune system. T-cells can destroy virally infected cells and tumor cells. However, there are several types of T-cells and several factors influence the resolution of central nervous system HSV-1 infections _ i.e. the cytotoxicity of T-cells, the precise timing of T- cell infiltration as well as the intervention of “neuroprotective” T-cells.

Vitamin E is the most important lipid-soluble antioxidant in the body. Dietary vitamin E levels regulate T-regulatory cells in the brain as well as the whole body. In other words, Vitamin E helps fight viruses including HSV-1 by influencing T-cell activity. This underlines the fact that vitamin E has good potential in the treatment and prevention of HSV-1 infections and cold sores.

Permalink -- click for full blog post "Vitamin E Helps Fight Cold Sores and Genital Herpes 1"


Jul 6, 2009, Herpes virus could be put to good use

Research presented to the 12th Annual Meeting of the American Society of Gene Therapy could bring hope to sufferers of malignant melanoma.

Melanoma is a deadly form of skin cancer, whose incidence in the United States has risen sharply over the past thirty years. It usually manifests itself in an abnormal skin growth or unusual moles, but can occasionally present in a number of other ways.

In a new study, involving fifty patients suffering from terminal, inoperable advance stage melanoma, participants were injected with Onco VEX GM-CSF, a genetically modified herpes simplex 1 virus.

The virus, which is easily modified, is capable of killing tumour cells both directly and by eliciting an immune response. Lead researcher Neil N. Senzer, M.D., described the test results as “highly provocative”. Preliminary studies have shown positive results in the treatment of breast cancer and other tumours with the modified herpes virus.

In the melanoma trials, fifty-eight percent of the patients achieved a one year survival rate and sixteen percent actually responded to treatment. The median survival was 16 months for all participants.

The causes of melanoma are multiple, and can include family history, exposure to arsenic compound found in some pesticides and extreme sensitivity to the sun.

Permalink -- click for full blog post "Herpes virus could be put to good use"


Jul 6, 2009, New Funds for Herpes Research

Gates helps fund herpes research

A cash injection of $100,000 from the Bill and Melinda Gates Foundation will help fund a new study. Lynda Morrison of St Louis University School of Medicine wants to determine whether a modified HSV-2 herpes virus can carry parts of the HIV gene into the body in order to stimulate the body’s defense system against HIV infection. Morrison gives an assurance that the modified HSV-2 virus cannot reproduce and cause herpes. In a hopeful message, she says: “By using a modified sexually transmitted disease virus vector, we may be able to reduce the chance of getting HSV-2 and HIV – all in one vaccine.”

Permalink -- click for full blog post "New Funds for Herpes Research"


May 18, 2009, Home Herpes Tests

Home herpes tests can offer confidentiality that no other tests can. They make it possible to get tested anonymously and receive a herpes diagnosis at home. Learn how accurate these tests are, which herpes testing solution to choose and why.

Permalink -- click for full blog post "Home Herpes Tests"


May 7, 2009, STD tests and testing

STD tests may become necessary if you have unusual symptoms near your genitals or if you have been recently diagnoses with one STD...

Permalink -- click for full blog post "STD tests and testing"


May 7, 2009, Herpes Testing and Herpes Tests

Herpes testing has become more and more accurate and affordable. If you have had herpes like symptoms, you should consider testing for herpes. Learn more now.

Permalink -- click for full blog post "Herpes Testing and Herpes Tests"


Apr 30, 2009, Genital Herpes Testing?

Genital herpes testing is necessary if you think you might have been infected or have unexplained herpes like symptoms.

Permalink -- click for full blog post "Genital Herpes Testing?"


Apr 30, 2009, Genital Herpes Blood Test, Testing and Diagnosis

A genital herpes blood test is recommended if you think you might have been infected or have unexplained genital herpes like symptoms. Learn more about genital herpes testing here...

Permalink -- click for full blog post "Genital Herpes Blood Test, Testing and Diagnosis"


Apr 30, 2009, PCR Herpes Test, Testing and Diagnosis

PCR herpes test give a very accurate results. You may want to use if you think you might have been infected or have unexplained herpes like symptoms.

Permalink -- click for full blog post "PCR Herpes Test, Testing and Diagnosis"


Apr 30, 2009, Herpes Blood Test, diagnosis and testing

A herpes blood test can be extremely accurate but which one should use, when and what to expect...

Permalink -- click for full blog post "Herpes Blood Test, diagnosis and testing"


Mar 3, 2009, Gardiasil withdrawn from Spanish Market by Local Authorities

Two teenage girls were hospitalized shortly after receiving HPV vaccine in Spain. They were in stable condition when this information was first released.

However, these incidents decided Spanish health authorities to withdraw Gardiasil from the Spanish market. They ceased a vaccination campaign they had previously launched throughout Spain shortly after.

The new HPV vaccine had become available in Spain in 2006.

(Source: AFP)

Permalink -- click for full blog post "Gardiasil withdrawn from Spanish Market by Local Authorities"


Mar 3, 2009, Herpes Pain Relief

Herpes pain relief was almost impossible to find. Pain killer didn't help at all and most creams where a waste of time until I've found organic silica gel.

Permalink -- click for full blog post "Herpes Pain Relief"


Feb 11, 2009, Why People with Herpes Should Avoid Drinking Soda

I recommend in my book Herpes Wise to reduce if not stop drinking any type of soda drinks. I believe it causes too many problems in the body for it to stay healthy. People with herpes have to take care of themselves a little bit more than other people. That's why I am very happy that doctor Mercola took the time to comment on an article that enumerated the adverse effects of soda drinks. Some of them are impaired digestion and liver damage. Poor digestion leads to a weakened immune system in the long run and is a big obstacle to keeping you outbreak free for life.
You can take a look at the article at http://articles.mercola.com/sites/articles/archive/2009/02/10/10-Diseases-Linked-To-Soda.aspx

Permalink -- click for full blog post "Why People with Herpes Should Avoid Drinking Soda"


Feb 3, 2009, Life Sciences Discovery Fund Awards cash to Support New Herpes Vaccine Program

Washington Life Sciences Discovery Fund (LSDF) has awarded nearly $4.7 million to launch Washington Vaccine Alliance (WAVA) supporting research into herpes vaccine. During the start-up phase, WAVA core operations will function within the Vaccine and Infectious Disease Institute of Fred Hutchinson Cancer Research Center.

WAVA is a consortium of seven not-for-profit research institutions, focused on providing the skills and apparatus necessary to develop, test and deploy new or improved vaccines for many of the world's most challenging diseases, including herpes.

Its structure will allow member organizations more effectively to develop and share critical skills and facilities, and partner with commercial pharmaceutical and biotech companies in herpes vaccine development and deployment.

"The successful development and deployment of even one vaccine will have a significant impact on the health of the citizens and will provide a very cost-effective intervention to reduce overall health care costs." said Larry Corey, M.D., principal investigator of the LSDF-funded project and co-director of the Vaccine and Infectious Disease Institute at the Hutchinson Center.

The LSDF award provides critical funding to complete the initial phases of three new vaccine projects, including the herpes vaccine and the ability to secure funding for the rest of the development process. The herpes vaccine project’s aim is to develop and produce a vaccine for preliminary clinical trials.

WAVA will create several core service centers, critical to bringing vaccines to market: discovery, development, production and deployment. These services will be extremely cost effective by taking advantage of existing expertise and sharing resources across the larger portfolio of vaccine projects. Member organizations will contract with each other to speed the testing and development process and The Hutchinson Center will oversee informatics and clinical trials design and management.

"Washington State has accumulated a critical mass of expertise in crucial areas necessary for the successful identification and development of vaccines. The creation of WAVA provides the catalyst to allow each member to create new programs that build upon the substantial existing successes," said King Holmes, M.D., Ph.D., chair of the University of Washington’s Department of Global Health.The portfolio of vaccine projects for WAVA covers major infectious diseases that await the development of effective and affordable vaccines. These include HIV, sexually transmitted infections such as genital herpes, hepatitis C, influenza, diarrheal diseases (especially of infants and children), pneumonia in the elderly and the pandemic infections of tuberculosis and malaria.

Permalink -- click for full blog post "Life Sciences Discovery Fund Awards cash to Support New Herpes Vaccine Program"


Jan 26, 2009, Activate to Exterminate is the new mantra for a Herpes Cure

We know by now how those painful and unsightly herpes cold sores around the mouth are caused by the herpes simplex virus type one (HSV-1). Some of us are lucky enough to be able to keep them at bay for long periods of time - and then some trigger like a fever, too much sunlight or stress in our lives causes them to come back all over again to give us more grief.

That is because even when the herpes virus isn’t actively punishing us with those horrid cold sores, it is still there, lurking in the depths where it can lay dormant sometimes for years.

Now professor Bryan Cullen, professor of molecular genetics and microbiology at Duke University, Durham NC has published findings which may go some way to finding that elusive cure for herpes. The principle is this: in order to kill the herpes virus, you must first activate it.

During non-active phases, the herpes HSV1 virus is present in the nervous system but does not reproduce itself. The same principle applies to the genitally transmitted herpes HSV2 virus and other latent viruses including the chickenpox virus. "Inactive virus is completely untouchable by any treatment we have. Unless you activate the virus, you can't kill it," says Professor Cullen.

When the virus is in its dormant phase it does not reproduce, and produces only one molecular product, called LAT RNA, which had always proved something of a mystery to scientists. Professor Cullen’s research has shown that LAT RNA is processed into smaller strands known as micro RNAs. These micro RNAs prevent the virus from reproducing itself until such time as a major stress in the patient causes the herpes virus to start its manufacturing process over again.

Professor Cullen and his team are currently testing a new drug which, if successful, will ‘kick start’ the herpes virus by binding the micro RNAs. This will cause the herpes virus to reproduce. The patient would then be treated with the drug acyclovir which effectively kills replicating HSV1 viruses.

"In principle, you could activate and then kill all of the virus in a patient. This would completely cure a person, and you would never get another cold sore.” said Professor Cullen.


Jan 16, 2009, Herpes and heterosexual HIV infection – No direct link


Researchers at Chicago’s Feinberg School of Medicine have debunked the myth that the HIV virus infects women only via areas of broken or damaged skin, such as herpes sores.

Until recently it had been assumed that the virus sought out herpes damaged skin in order to reach the immune system cells deeper in the tissue. Some scientists had even thought the normal (i.e. uninfected with herpes) lining of the vaginal tract offered protection from HIV infection during intercourse, aggravating an unpleasant stigma for herpes sufferers.

But Thomas Hope, Professor of cell and molecular biology at Northwestern University now admits: “Normal skin is vulnerable.” Professor Hope and others developed a new method of observing HIV by introducing a strain of the virus carrying fluorescent, light-activated tracers into vaginal tissue samples in a laboratory environment.

Scientists who hitherto had little understanding of how HIV infected women during intercourse were able to observe under the microscope how the virus was able quickly to penetrate the genital skin to reach immune cells. Professor Hope said the study indicated that the virus targets areas of skin which have recently shed skin cells and cast doubt on the previous theory that the virus required damaged or broken skin to penetrate.

He added that this could explain why a clinical trial in Africa using a diaphragm to block the cervix produced no reduction in HIV transmission and also why studies of drugs designed to prevent lesions in genital herpes had proved ineffective.

Emphasizing how this study underlines the need for vaccine treatments to prevent HIV infection, Professor Hope added: “People need to remember that they are vulnerable. The sad part is if people just used a condom, we wouldn’t have this problem.”

In the United States, HIV continues to be predominantly passed via male homosexual activity. Women account for 26 percent of all new HIV cases in the USA, according to the US Center for Disease Control and Prevention.

Permalink -- click for full blog post "Herpes and heterosexual HIV infection – No direct link"


Dec 5, 2008, A baby was “killed” by a cold sore in the UK

A newborn baby girl came in contact with oral herpes while her mother was having a first oral herpes infection and kissed her. The little girl who had not developed her immune system and had not received herpes antigen from her mom soon died after that. It is assessed that about 90% of the adult population has oral herpes. Therefore this case is quite uncommon but it sadly reminds us that we have to pay extra attention to newborn babies and that cold sores and herpes even though harmless to most healthy adults can become deadly to very young infants.

Dr. Herbert Kaufman, Boyd Professor of Ophthalmology at Louisiana State University Health Sciences Center in New Orleans found that 98% of the participants of his study did have herpes simplex virus type I (HSV-1) DNA in their tears and saliva at least once during the course of the 30-day study. None of these participants had shown any signs or symptoms of oral herpes. This study used the most up-to-date techniques for herpes diagnosis. Therefore its finding can be considered as full proof that almost all adult population has oral herpes whether they are aware of it or not. This is why it is really important to remember this while dealing with newborn babies.

Click for more info


Nov 28, 2008, Herpes Cure : Good News !

Cellectis (http://www.cellectis.com/applications.php) and Genomic Visio receive a 10 million euro loan to develop a revolutionary herpes cure.Celletics specializes in genome engineering and Genomic vision in molecular diagnosis. Together, they will work on project ACTIVE, to see how they can use celletic findings to cure herpes even at dormant stage by removing herpes genome from host cells with a revolutionary new kind of antiviral agents.

If they succeed, herpes could become just a bad memory for all humanity. This is the most promising project I know of because it could not only prevent herpes from shedding or replicating but entirely remove herpes from one's body. I know from my numerous contacts with people with herpes that this is the kind of cure they're all hoping for.

Permalink -- click for full blog post "Herpes Cure : Good News !"


Oct 28, 2008, 28% of Women Will Get Genital Herpes by the Age of 49

According to the World Health Organization (WHO), genital herpes may infect 28% of all women worldwide by the time they reach 45.
This percentage varies according to countries and reaches 70% in some areas of sub- Saharan Africa.

The WHO reports that women are at greater risk of catching herpes than men.

Unfortunately, these findings confirm the Worldwide trends that the WHO had found in 2003. They had then reported that "The total number of people aged 15–49 years who were living with HSV-2 infection worldwide in 2003 is estimated to be 536 million, while the total number of people who were newly infected with HSV-2 in 2003 is estimated to be 23.6 million. While the estimates are limited by poor availability of data, general trends are evident. For example, more women than men were infected, and the number infected increased with age. Although prevalence varied substantially by region, predicted prevalence was mostly higher in developing regions than developed regions."

http://www.who.int/en/

Permalink -- click for full blog post "28% of Women Will Get Genital Herpes by the Age of 49"


May 22, 2008, Join Nathalie's Free Conference Call about Herpes

I will be holding a phone conference this Friday. This is a one time event.

I will reply to a lot of questions that my readers have asked me. I will cover everything from herpes transmission to herpes cure, herpes prevention and all issues concerning herpes and genital herpes.

Get more info now at http://www.herpes-antidote.com/teleseminar-subscribe.html

or join the conversation at http://herpes-antidote.com/secret/

Click for more info


May 13, 2008, Seeking More American Volunteers To Test a New Herpes Drug

If you want to help science find new herpes drugs or vaccine, you should participate in a clinical study.

That's why I want to share with you a great website which gathers all information on ongoing herpes research and clinical studies in the US.

I have created a link for you where you can see all current or recent herpes clinical studies. On the left side of the page you can see if these studies are still recruiting.

HSV, Herpes Clinical Studies

Permalink -- click for full blog post "Seeking More American Volunteers To Test a New Herpes Drug"


May 9, 2008, Seeking Volunteers To Test a New Herpes Drug

Asha, the American Social Health Association is recruiting volunteers to test a new herpes drug.You can find further information at http://www.ashastd.org/trial.cfm#WA


May 8, 2008, More HPV Vaccine Deaths On the Way?

Here is an excerpt of Dr Mercola's comment about the use of male HPV vaccine as a way to prevent cancer. * About 90 percent of all HPV infections go away on their own within two years. * A JAMA study found that just 2 percent of the patients in the study were infected by the kinds of HPV that put them at high-risk for developing cervical cancer. * A little more than 3 percent were infected with the types of HPV that Gardasil was concocted to prevent.I find it very interesting that Gardiasil which may have caused deaths to several little girls (read my blog post below) was actually useful to only 3 percent of them.

Make sure to read Dr Mercola's comment below the small article that precedes it. It really is an eye opener.

Click for more info


Apr 21, 2008, No More Persecution against People with Herpes. This Time This Is Too Much!

A sadistic and resentful ex-boyfriend distributed pornographic fliers displaying his ex having sex with disease carrier written across because he knew she had herpes.

He just couldn't handle being dumped or so it seemed so he started faxing these fliers at his ex girlfriend workplace and outside her son's middle school as revenge. He's now being prosecuted for giving that information out. I hope he goes to jail and gets to pay a huge fee.

What saddens me most is that he didn't care for her ex poor son who has been traumatized for seeing his mother displayed like that. Who thinks about the kids? It seems not enough people. I think CBS coverage of the story is pathetic and fails to see the trial stakes. You can read it here http://cbs4.com/local/Hance.Adams.broward.2.701538.html

I wonder if people with herpes will have to create their own lobby to get the respect and privacy they deserve.


Apr 15, 2008, Gardasil vaccine! Could It Kill Your Daughter Too?

Judicial watch whose goal is to protect justice and US citizens has filed a complaint against the FDA after receiving eight death reports related to the new HPV vaccine. This along with the 1,824 adverse reaction reports makes it urgent to disclose this information to the public.

I must say I was really excited about this new led free vaccine. I felt it was very promising.

I am shocked, disappointed and feel deeply saddened by the whole situation.

This took place in 2007 and I haven't found any updates on the story yet but I felt I should let you know anyway.

You can read more at http://www.judicialwatch.org/6428.shtml


Apr 11, 2008, Shocking Truths About GlaxoSmithKline Marketing Tactics

You may start to think that I hate pharmaceutical companies and that I just want to say nasty things about them. I don't. They once saved my life and this is not something you can easily forget. However I want them to loose their trustworthy Godlike reputation. My mother and maybe you or your relatives usually take the words of their doctors or pharmaceutical companies as absolute truths. I often hear my mom say "They said it so it's true no questions about it." It may have been true when she grew up but it has now become more and more obvious that times have changed. Dr Mercola and the Washington Post give a more brutal but honest report of the situation.

Here is a excerpt from Dr Mercola's blog who is referring to a Washington Post article.

"In 1950, George Merck, president of the company founded by his father and bearing his name, said, "We try never to forget that medicine is for the people. It is not for the profits."

If that was ever true, it is certainly not true now. Drug companies are hugely profitable enterprises, and they spent more on political lobbying than any other industry between 1998 and 2004. The transformation is owed in large measure to blockbuster drugs, meaning any medication that generates more than $1 billion in sales annually.

It might have begun with the selling of Zantac, an anti-ulcer drug that came on the market in 1983. GlaxoSmithKline priced it more expensively than the competitor drug Tagamet, to imply that it was superior. In reality, Zantac was chemically almost identical to Tagamet and no more effective. "

GlaxoSmithKline manufactures and promotes 2 herpes drugs under the brand names of Zovirax and Valtrex. One is no longer patented whereas the other is. Could the same thing be happening with them? I gave a precise answer to that question in Herpes Wise a book helping people with genital herpes more than 3 years ago. Answers are available to those who want to take a closer look rather than be hypnotized by expensive publicity campaigns.

You can read the Washington Post article here

Permalink -- click for full blog post "Shocking Truths About GlaxoSmithKline Marketing Tactics"


Apr 6, 2008, Doctors Get Rewarded For Pushing Drugs

Hey Doc! Want a new swimming pool for summer? Well if you sell my drug 3 times more than you normally do in the next 3 months, I'll drop you a little bonus.

I'm sure this conversation seems absurd. How could doctors compromise the health of their patients to get financial reward?

Well, it happens and more often than you can imagine. A former Eli Lilly Rep broke the silent in front of a Congressional committee last month. He explained how he was trained to wine and dine doctors and use sexual tension to make a sale. Makes me wonder which other pharmaceutical companies would train their reps to do the same? Anyway, this testimonial hurts their reputation once more.

http://abcnews.go.com/US/story?id=4438095&page=1

Permalink -- click for full blog post "Doctors Get Rewarded For Pushing Drugs"


Apr 4, 2008, A Real Curative Herpes Vaccine Could Be On Its Way!

This is the first time that a useful vaccine for herpes is being researched. By useful, I mean a vaccine that has the potential to cure herpes, not just prevent it.

Vical, Inc. has been awarded a $2 million Phase II small business technology transfer grant from the US National Institute of Allergy and Infectious Diseases department from the National Institutes of Health.

The grant is to fund an ongoing development of Vical's plasmid DNA vaccine against Herpes simplex virus type 2.

Research is being conducted at the University of Washington,a world-renowned leader in herpes research and the University of Texas.

The goal of the study is to see if they can reduce or eliminate recurrent herpes viral flare-ups, shedding and transmission.

This would mean the end of herpes pandemic and a real breakthrough for humanity who has been trying to cure herpes since the Greek era.

You can enroll here http://depts.washington.edu/herpes/

Permalink -- click for full blog post "A Real Curative Herpes Vaccine Could Be On Its Way!"


footer for herpes treatments page